GENPREX (GNPX) vs Valion Bio, Inc. (VBIO)
GENPREX and Valion Bio, Inc. are both Biotechnology companies. GENPREX and Valion Bio, Inc. are of similar size ($3.0M and $2.8M). Valion Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 11 metrics below, GENPREX leads on 9 and Valion Bio, Inc. on 2.
Valuation
Profitability
| Metric | GNPX | VBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (58.09%) | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (203.86%) | (489.30%) | (57.72%) |
| Return on assets | (157.40%) | (104.96%) | (49.22%) |
| Return on invested capital | 0.00% | (61.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack